General Forum, page-1437

The team is fully focused on lodging the Conneqt band with the FDA in the 2nd half of 2023. It will be the first cuff-less wearable with FDA approved clinical advanced heart bio markers, building on top of the growing adoption and brand awareness of the Pulse as the gold standard for the management of cardiovascular disease globally. Remember what Craig has said several times "we are the only company working on this, there is no else at the level." Love buying a company with such a ridiculously low valuation poised to explode in the short to medium term. Thank you for those 18 cent shares this morning.